EGR1 TARGETING MOLECULES FOR THE TREATMENT OF INFLAMMATORY AND HYPERPROLIFERATIVE CONDITIONS
申请人:The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center
公开号:US20180289728A1
公开(公告)日:2018-10-11
A method of treating an inflammation or a hyperproliferative disease in a subject in need thereof is disclosed. The method comprising administering to the subject a therapeutically effective amount of a compound selected from the group consisting of:
a compound represented by Formula I:
or a pharmaceutically acceptable salt thereof,
a compound represented by Formula II:
and a compound represented by Formula III:
wherein the variables in Formulae I, II and III are as defined in the specification.